Andere talen RTW Biotech Opportunities Ltd

Aandelen

RTW

GG00BKTRRM22

Gesloten eindfondsen

Beurs gesloten - London S.E. Andere beurzen 17:35:14 12-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,460 ^USD	-0,68%		-3,95%	+4,10%

10/12	RTW Biotech Opportunities Ltd kondigt de benoeming aan van Baroness Nicola Blackwood als Senior Independent Non-Executive Director	CI
15/11	RTW Biotech stelt vast dat medicijn Corxel in China is goedgekeurd	AN

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

RTW Biotech Opportunities Ltd Announces Appointment of Baroness Nicola Blackwood as Senior Independent Non-Executive Director	10/12
RTW Biotech notes drug approval in China for investee Corxel	15/11
RTW Biotech invests in inflammation treatment firm Evommune	04/11
RTW Biotech Opportunities announces launch of Kailera Therapeutics	03/10
RTW Biotech Opportunities Co-leads $400 Million Financing in Kailera Therapeutics	03/10
RTW Biotech invests in cancer treatment firm Aktis Oncology	02/10
RTW Biotech Opportunities Co-leads Financing Round for Aktis Oncology	02/10
RTW Biotech notes BioAge Labs' USD198 million initial public offering	27/09
RTW Biotech Opportunities to Halt Trading in GBP Quote on London Bourse	26/09
RTW Biotech half-year net asset value rises amid "challenging markets"	13/09
RTW Biotech Opportunities' H1 Net Investment Loss Widens	13/09
RTW Biotech Opportunities : Half Yearly Report	13/09
RTW Biotech Opportunities Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	13/09
EARNINGS AND TRADING: Epwin in line; Airea's "unforeseen slowdown"	06/08
RTW Biotech Opportunities Invests in Jade Biosciences	06/08
RTW Biotech Opportunities Ltd Appoints Baroness Nicola Blackwood as an Independent, Non-Executive Director	11/07
RTW Biotech Opportunities Invests in Mirador Therapeutics, Santa Ana Bio	02/07
RTW Biotech touts private investing activity following new investments	02/07
Christie trading improved, maintains expectations	13/06
RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	11/06
RTW Biotech Opportunities Ltd commences an Equity Buyback Plan for 57,844,388 shares, representing 14.99% of its issued share capital, under the authorization approved on May 16, 2024.	30/05
RTW Biotech Opportunities Ltd?s Equity Buyback announced on July 20, 2023, has expired.	16/05
Future Metals celebrates state government grant	15/05
RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round	15/05
RTW Biotech Opportunities : Publication of Circular and notice of General Meeting	18/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen RTW Biotech Opportunities Ltd

Aandelen

RTW

GG00BKTRRM22

Gesloten eindfondsen

Andere talen

Filters